OR WAIT 15 SECS
Aker BioMarine scientists and members of the company's Science Advisory Board met to discuss future studies and krill sustainability.
Reporting on a recent meeting between its R&D scientists and its Science Advisory Board, Aker BioMarine (Oslo, Norway) says it is planning a future study on krill for joint health and inflammation for later this year. The krill ingredients supplier plans to incorporate krill oils and powders in the human study.
Sustainability of krill resources was also discussed at the recent meeting. Researchers concluded that there is still no sign of krill catch affecting any populations of krill predators.
Related Content:Joint & Bone Health